☰

Bryann R. Baker, Ph.D.

Affiliations: 
2012 Psychology University of Maryland, College Park, College Park, MD 
Google:
"Bryann Baker"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Jack Blanchard grad student 2012 University of Maryland
 (Schizophrenia-spectrum behavior and peer responses to individuals with social anhedonia.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ashton WT, Kirk LL, Baker BR. (1973) Irreversible enzyme inhibitors. 198. Diaminodihydro-S-triazines and diaminopyrimidines bearing substituted (ureidomethyl)phenyl substituents as reversible inhibitors of dihydrofolate reductase. Journal of Medicinal Chemistry. 16: 453-6
Baker BR, Ashton WT. (1973) Irreversible enzyme inhibitors. 197. Water-soluble reversible inhibitors of dihydrofolate reductase with potent antitumor activity derived from 4, 6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. Journal of Medicinal Chemistry. 16: 209-14
Baker BR, Ashton WT. (1972) Irreversible enzyme inhibitors. 196. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine and bearing a terminal phenyl sulfonate group. Journal of Medicinal Chemistry. 15: 945-7
Baker BR, Schaefer JC. (1971) Irreversible enzyme inhibitors. 187. Studies on bulk tolerance with inhibitors of guanosine phosphorylase. Journal of Medicinal Chemistry. 14: 809-12
Baker BR, Siebenneick HU. (1971) Irreversible enzyme inhibitors. 185. Active-site-directed irreversible inhibitors of guanine deaminase derived from 9-phenylguanine bearing a terminal sulfonyl fluoride. 2. Journal of Medicinal Chemistry. 14: 802-5
Baker BR, Doll MH. (1971) Irreversible enzyme inhibitors. 183. Proteolytic enzymes. 18. Inhibitors of guinea pig complement derived by quaternization of phenylalkylpyridines with -bromomethylbenzenesulfonyl fluorides. Journal of Medicinal Chemistry. 14: 793-9
Baker BR, Kelley JL. (1971) Irreversible enzyme inhibitors. 188. Inhibition of mammalian thymidine phosphorylase. Journal of Medicinal Chemistry. 14: 812-6
Baker BR, Ashton WT. (1970) Irreversible enzyme inhibitors. CLXXIX. Active-site-directed irreversible enzyme inhibitors of dihydrofolate reductase from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with oxyamide bridges to a terminal sulfonyl fluoride. Journal of Medicinal Chemistry. 13: 1165-70
Baker BR, Ashton WT. (1970) Irreversible enzyme inhibitors. 178. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with a terminal sulfonyl fluoride. Journal of Medicinal Chemistry. 13: 1161-5
Baker BR, Vermeulen NM. (1970) Irreversible enzyme inhibitors. CLXXVII. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(phenylalkylphenyl)-s-triazines. II. Journal of Medicinal Chemistry. 13: 1154-60
See more...